| abstract |
The invention describes a composition comprising a new strain of European PRRSV, or proteins at least 98% identical to SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6 , SEQ ID NO: 7, SEQ ID NO: 8 and SEQ ID NO: 9, containing this composition, a product representing a vaccine, and their use, as well as an isolated nucleic acid and a recombinant expression vector intended for obtaining proteins included in the claimed composition. |